NHS
NHS Better Care Fund lacks guidance, says watchdog
November 12, 2014Sales and Marketing England, NHS, UK, better care fund, nao
A much-lauded project to reduce unnecessary hospital visits and shift care into the community will fall well short of its …
Doctors warn of urgent care ‘chaos’
November 12, 2014Sales and Marketing BMA, GPs, NHS, doctors, nagpaul, pac
Doctors’ leaders are demanding greater investment in out-of-hours GP services, warning of ‘fragmentation’ and underfunding, and branding the current system …
GPs to ‘prescribe’ apps
November 11, 2014Medical Communications, Sales and Marketing Apple, Frost & Sullivan, GPs, NHS, Samsung, UK, apps, eHealth, prescribing
General practitioners in the UK are to begin ‘prescribing’ health apps as part of a move to better monitor issues …
Doctors must help NHS save money, says report
November 7, 2014Medical Communications, Sales and Marketing Academy of Medical Royal Colleges, GPs, NHS, government, hospitals
A report has suggested the National Health Service could make nearly £2 billion in cost savings if doctors ‘provided more …
Wales Assembly facing questions over cancer
November 5, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology
The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …
Sir Michael Rawlins appointed chair of MHRA
November 4, 2014Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins
The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …
NICE backs GSK’s leukaemia drug Arzerra following price cut
November 4, 2014Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia
NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …
UK doctors are ignoring statin guidance
November 3, 2014Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins
A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …
NICE recommends new indication for troubled Pradaxa
October 31, 2014Sales and Marketing Boehringer, NHS, NICE, Pradaxa, dabigatran, ingelheim, warfarin
NICE has recommended Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa for treating and preventing potentially-fatal blood clots in the legs …
Innovation director appointed to NHS England
October 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS England, tony young
NHS England has hired a new national clinical director for innovation in Professor Tony Young. Young’s role will be to …
NICE under increased pressure over conflicts of interest
October 22, 2014Sales and Marketing GPs, NHS, NICE, UK, baker, conflict, mccoll, wollaston
A group of influential doctors is calling on the government to tighten up NICE’s conflicts of interests policy. In a …
Medicine Innovation Bill a step closer in UK
October 20, 2014Sales and Marketing BBC, DH, NHS, innovation bill, saatchi
A new bill proposed by Conservative peer Lord Saatchi has been given government backing as it seeks to become law …
Pharmacists could save the NHS £1.1 billion
October 20, 2014Sales and Marketing GP, GPs, NHS, UK, pharmacists
New research from the Royal Pharmaceutical Society shows that common ailments such as coughs and sore throats cost the NHS …
Novartis cancer drug beating path to NHS
October 17, 2014Sales and Marketing GIST, Glivec, NHS, NICE, imatinib, uturn
NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …
NICE not recommending Dendreon cancer vaccine
October 16, 2014Sales and Marketing Dendreon, NHS, NICE, Provenge, sipuleucel-T, therapeutic cancer vaccine
NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
